Ze-Hong Miao (Zehong Miao)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Endoplasmic Reticulum Stress

Dna Damage Response

Top Venues

EMBO molecular medicine

Molecular cancer research : MCR

Cell death & disease

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine 15 (3) (2023)
Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine 15 (3) (2023)
Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine 15 (3) (2023)
Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine 15 (3) (2023)
Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine (2023)
Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine 15 (3) (2023)
Lin Sun, Qian Wu, Xia-Juan Huan, Chang-Qing Tian, Ying-Qing Wang, Ze-Hong Miao
Loss of VOPP1 Contributes to BET Inhibitor Acquired Resistance in Non-Small Cell Lung Cancer Cells. Molecular cancer research : MCR 20 (12) (2022)
Yiyue Ge, Tingzhong Tian, Suling Huang, Fangping Wan, Jingxin Li, Shuya Li, Xiaoting Wang, Hui Yang, Lixiang Hong, Nian Wu, Enming Yuan, Yunan Luo, Lili Cheng, Chengliang Hu, Yipin Lei, Hantao Shu, Xiaolong Feng, Ziyuan Jiang, Yunfu Wu, Ying Chi, Xiling Guo, Lunbiao Cui, Liang Xiao, Zeng Li, Chunhao Yang, Ze-Hong Miao, Ligong Chen, Haitao Li, Hainian Zeng, Dan Zhao, Fengcai Zhu, Xiaokun Shen, Jianyang Zeng
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. Signal transduction and targeted therapy 6 (1) (2021)
Ning Zhang, Yu-Nan Tian, Li-Na Zhou, Meng-Zhu Li, Hua-Dong Chen, Shan-Shan Song, Xia-Juan Huan, Xu-Bin Bao, Ao Zhang, Ze-Hong Miao, Jin-Xue He
Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer. Cell death & disease 12 (2) (2021)